secretory phospholipase A2 receptor (PLA2-R, PLA2R, 180 kD secretory phospholipase A2 receptor, M-type receptor) [Contains: soluble secretory phospholipase A2 receptor (Soluble PLA2-R, Soluble PLA2R)] (PLA2R1)
Jump to navigation
Jump to search
Function
- precise function uncertain
- receptor for secretory phospholipase A2 (sPLA2)
- acts as a receptor for phosholipase sPLA2-IB/PLA2G1B but not sPLA2-IIA/PLA2G2A
- able to bind to snake PA2-like toxins
- binding of sPLA2 to its receptor participates in both positive & negative regulation of sPLA2 functions as well as clearance of sPLA2
- binding of sPLA2-IB/PLA2G1B induces various effects depending on cell type, including
- activation of MAPK cascade to induce cell proliferation
- production of lipid mediators
- selective release of arachidonic acid in bone marrow- derived mast cells
- in neutrophils, binding of sPLA2-IB/PLA2G1B can activate p38 MAPK to stimulate elastase release & cell adhesion
- may be involved in responses in proinflammatory cytokine productions during endotoxic shock
- also has endocytic properties & rapidly internalizes sPLA2 ligands,
- the soluble secretory phospholipase A2 receptor form is circulating & acts as a negative regulator of sPLA2 functions by blocking the biological functions of sPLA2-IB/PLA2G1B
- the secretory phospholipase A2 receptor form may be produced by the action of metalloproteinases; it
- contains all extracellular domains & only lacks transmembrane & cytosolic regions; unclear whether secretory form is produced by proteolytic cleavage or by alternative splicing
Structure
- C-type lectin domains 3-5 mediate the interaction with phospholipase PLA2G1B
- endocytosis signal probably mediates endocytosis via clathrin-coated pits (putative)
- contains 8 C-type lectin domains
- contains 1 fibronectin type-2 domain
- contains 1 ricin B-type lectin domain
Compartment
Alternative splicing
named isoforms=2
Expression
- present in lung macrophage (at protein level)
- highly expressed in kidney
- also expressed in pancreas, amnion, choriodecidua & placenta
- isoform 2 is expressed at much lower level
Pathology
- 85% of membranous glomerulonephritis with PLA2R antibody